Could a common Alzheimer's drug boost stroke recovery?
NCT ID NCT02144584
First seen Dec 29, 2025 · Last updated May 03, 2026 · Updated 18 times
Summary
This early-stage study tests whether memantine, a drug used for Alzheimer's, can improve arm and leg movement after a stroke. Twenty adults who had an ischemic stroke and have arm weakness will receive either memantine or a placebo. Researchers will measure motor function and track side effects over 8 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Utah
Salt Lake City, Utah, 84132, United States
Conditions
Explore the condition pages connected to this study.